Comparing the effect of levostatin + Descurainia sophia and levostatin in lowering LDL cholesterol in patients with cardiovascular disease, A Clinical trial

Phase 2

• Conditions: Condition 1: Cardiovascular diseases. Condition 2: cardiovascular diseases.; Atherosclerosis; Pure hypercholesterolaemia

• Registration Number: IRCT2013012612277N1
• Lead Sponsor: Vice Chancellor for research of Lorestan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

cardiovascular patients; aged between 40 to 70 years; LDL cholesterol more than 160 miligram/dl

Exclusion criteria: taking anti - lipids, steroids or statins; suffering from diabetes, hypothyroids and nephritic syndrome

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in LDL cholesterol. Timepoint: Before intervention and 5 months after intervention. Method of measurement: With Liberman- Buchard method.